Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$49,861,961
+$6,845,920 QoQ
Shares Held
198,148
+0.2% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
1.84%
of 13F equity value
Holder Rank
#363
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Argent Trust Co holds $201,801,045 across 13 Drug Manufacturers - General names. ABBV ranks #1 (24.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
198,148 | $49,861,961 | |
| 2 | JNJ |
Johnson & Johnson
|
191,349 | $48,596,904 | |
| 3 | LLY |
ELI LILLY & Co
|
29,355 | $35,209,269 | |
| 4 | MRK |
Merck & Co., Inc.
|
204,960 | $26,337,359 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
86,362 | $10,910,974 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
134,450 | $7,747,007 | |
| 7 | AMGN |
Amgen Inc
|
20,391 | $7,383,988 | |
| 8 | NVS |
Novartis AG
|
39,948 | $6,260,649 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,861,961 | 198,148 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $43,016,041 | 197,784 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $45,214,056 | 197,882 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $47,476,117 | 205,045 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $38,639,400 | 208,164 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $42,209,688 | 201,459 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $35,615,699 | 200,426 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $39,473,486 | 199,886 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $35,019,581 | 204,172 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $36,837,009 | 202,290 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $30,847,862 | 199,057 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $29,351,106 | 196,908 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $26,432,139 | 196,186 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $29,407,747 | 184,525 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $29,053,921 | 179,778 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $24,243,961 | 180,642 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $27,002,566 | 176,303 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $28,475,593 | 175,656 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $23,894,443 | 176,473 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $18,899,470 | 175,206 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $19,111,289 | 169,667 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $15,203,286 | 140,485 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $14,503,608 | 135,358 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $11,522,200 | 131,547 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $12,563,504 | 127,964 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $8,629,583 | 113,264 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||